These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 44617

  • 1. Structural changes of Toxoplasma gondii bradyzoites and cysts following therapy with sulfamethoxypyrazine-pyrimethamine: studies by light and electron microscopy. Consequences for chemotherapy.
    Werner H, Matuschka FR, Brandenburg I.
    Zentralbl Bakteriol Orig A; 1979 Oct; 245(1-2):240-53. PubMed ID: 44617
    [Abstract] [Full Text] [Related]

  • 2. The effect of sulfomethoxypyrazine-pyrimethamine therapy on the fine structure of Toxoplasma gondii-cysts in the brain of Mastomys natalensis. Scanning and transmission electron microscopical investigations.
    Matuschka FR.
    Zentralbl Bakteriol Orig A; 1977 Jul; 238(3):419-29. PubMed ID: 910581
    [Abstract] [Full Text] [Related]

  • 3. The effect of chemo-immunotherapy with SDDS, pyrimethamine and anti-toxoplasma serum on toxoplasma gondii cysts in latent infected NMRI mice.
    Werner H, Masihi KN, Tischer I, Adusu E.
    Tropenmed Parasitol; 1977 Dec; 28(4):528-32. PubMed ID: 601857
    [Abstract] [Full Text] [Related]

  • 4. [Experimental study of the activity of the sulphamethoxypyrazine (Longum equals Kelfizina) with pyrimethamine (Daraprim) on the cysts development phase of Toxoplasma gondii in Mastomys natalensis. Further contribution to experimental chemotherapy of toxoplasmosis (author's transl)].
    Werner H, Egger I.
    Zentralbl Bakteriol Orig A; 1974 Jun; 226(4):554-60. PubMed ID: 4152678
    [No Abstract] [Full Text] [Related]

  • 5. [New pathogens and mode of action of azithromycin: Toxoplasma gondii].
    Derouin F.
    Pathol Biol (Paris); 1995 Jun; 43(6):561-4. PubMed ID: 8539083
    [Abstract] [Full Text] [Related]

  • 6. Chemotherapy of experimental toxoplasmosis with special reference to robenidine.
    Bakhtari SK, Jíra J.
    Folia Parasitol (Praha); 1988 Jun; 35(3):193-8. PubMed ID: 2974008
    [Abstract] [Full Text] [Related]

  • 7. Effect of cortisone on Toxoplasma gondii infection studied by electron microscopy.
    Hulínská D, Sýkora J, Zástĕra M.
    Folia Parasitol (Praha); 1990 Jun; 37(3):207-12. PubMed ID: 2227703
    [Abstract] [Full Text] [Related]

  • 8. [Preliminary application of PCR to curative effect assessment of chemotherapy against experimental acute infection of Toxoplasma gondii in mice].
    Xiang X, Ke OY, Zhang Z.
    Hunan Yi Ke Da Xue Xue Bao; 1997 Jun; 22(1):5-7. PubMed ID: 9868016
    [Abstract] [Full Text] [Related]

  • 9. Use of molecular and ultrastructural markers to evaluate stage conversion of Toxoplasma gondii in both the intermediate and definitive host.
    Ferguson DJ.
    Int J Parasitol; 2004 Mar 09; 34(3):347-60. PubMed ID: 15003495
    [Abstract] [Full Text] [Related]

  • 10. Studies on the activity of Obioactin with acetylspiramycin on mice infected with Toxoplasma gondii.
    Suzuki N, Espinas FM, Sakurai H, Saito A, Sasaki H, Kato G, Manba K, Taniguchi K, Mochizuki K, Osaki H.
    Zentralbl Bakteriol Mikrobiol Hyg A; 1984 Mar 09; 256(3):367-80. PubMed ID: 6730783
    [Abstract] [Full Text] [Related]

  • 11. [A comparison of Ultrax, Diazil, Bactrim and Spiramycin in experimental toxoplasmosis in mice (author's transl)].
    Coradello H, Kretschmer S.
    Wien Klin Wochenschr; 1978 Jan 06; 90(1):25-9. PubMed ID: 625985
    [Abstract] [Full Text] [Related]

  • 12. Unexpected oocyst shedding by cats fed Toxoplasma gondii tachyzoites: in vivo stage conversion and strain variation.
    Dubey JP.
    Vet Parasitol; 2005 Nov 05; 133(4):289-98. PubMed ID: 16024176
    [Abstract] [Full Text] [Related]

  • 13. Effect of pyrimethamine and sulfadiazine on the fine structure and multiplication of Toxoplasma gondii in cell cultures.
    Sheffield HG, Melton ML.
    J Parasitol; 1975 Aug 05; 61(4):704-12. PubMed ID: 1165554
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Construction of Toxoplasma gondii bradyzoite expressing the green fluorescent protein.
    Nishikawa Y, Zhang H, Ibrahim HM, Ui F, Ogiso A, Xuan X.
    Parasitol Int; 2008 Jun 05; 57(2):219-22. PubMed ID: 18006371
    [Abstract] [Full Text] [Related]

  • 16. [Effect of pyrimethamine sulfadoxine (Fansidar) on an avirulent cystogenic strain of Toxoplasma gondii (Prugniaud strain) in white mice].
    Garin JP, Brossier N, Tran Manh Sung R, Moyne T.
    Bull Soc Pathol Exot Filiales; 1985 Jun 05; 78(5 Pt 2):821-4. PubMed ID: 3836770
    [No Abstract] [Full Text] [Related]

  • 17. [Experimental studies of the activity of certain drugs on zoites and cyst development of toxoplasma gondii in NMRI mice].
    Werner H, Dannemann R.
    Z Tropenmed Parasitol; 1972 Mar 05; 23(1):63-77. PubMed ID: 5050533
    [No Abstract] [Full Text] [Related]

  • 18. Toxoplasma gondii: in vitro and in vivo activities of the hydroxynaphthoquinone 2-hydroxy-3-(1'-propen-3-phenyl)-1,4-naphthoquinone alone or combined with sulfadiazine.
    Ferreira RA, Oliveira AB, Ribeiro MF, Tafuri WL, Vitor RW.
    Exp Parasitol; 2006 Jun 05; 113(2):125-9. PubMed ID: 16458300
    [Abstract] [Full Text] [Related]

  • 19. [Evaluation of the efficacy of azithromycin and pyrimethamine, for treatment of experimental infection of mice with Toxoplasma gondii cystogenic strain].
    Lescano SA, Amato Neto V, Chieffi PP, Bezerra RC, Gakiya E, Ferreira CS, Braz LM.
    Rev Soc Bras Med Trop; 2004 Jun 05; 37(6):460-2. PubMed ID: 15765594
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.